Top compounds associated with response to GADL1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.086 0.005
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.1 0.005
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.14 0.005
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.092 0.005
mRNA ELCPK CTRPv2 pan-cancer AAC 0.15 0.005
mRNA HLI 373 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.11 0.006
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.083 0.006
Download CSV